跳至主要内容
临床试验/DRKS00027405
DRKS00027405已完成未知

Evaluation of the Impact of Vitadio on HbA1c in Patients with Type 2 Diabetes mellitus in daily practice - EIVE

Vitadio Health Technologies GmbH0 个研究点目标入组 149 人开始时间: 2022年9月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
149

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • •Type 2 diabetes patients benefitting from improved self-management
  • •Patients not having used Vitadio in the past
  • •Patients using/willing to use Vitadio as part of their diabetes management
  • •HbA1c at baseline = 7.5 % and = 11.0 %
  • •Patients with internet access and a computer and/or smartphone compatible with Vitadio
  • •Digital literacy to use a smartphone adequately and willing to use it for their diabetes self-management
  • •Sufficient understanding of user interface (UI) of Vitadio
  • •Patients currently adjusting their diabetes management and lifestyle based on the self-testing of blood glucose at home
  • •Participants willing and able to comply with all scheduled visits, laboratory tests, lifestyle considerations and other study procedures
  • •Participants capable of giving personal signed informed consent

排除标准

  • •Patients using other Apps for their diabetes management
  • •Patients who have been using Vitadio in the past twelve months
  • •Patients with impairments – including mental or psychic impairments – or conditions which, in the opinion of the investigator, would seriously compromise the integrity of the study
  • •Patients under 18 years of age
  • •Patients already using an insulin pump
  • •Patients currently participating in a weight loss program
  • •Steroid therapy within the last three months; topic or inhaled use is no exclusion criterion when not used regularly (more than five times a week)
  • •Uncontrolled blood pressure = 200 mmHg at screening
  • •Body mass index (BMI) > 40 kg/m²
  • •Current pregnancy or pregnancy planned during the study, or breastfeeding women
  • •Alcohol or drug abuse within the last three months
  • •Patients with home health aides who assist with their BG testing and/or insulin adjustment
  • •Current participation in another trial or study
  • •Employees of Vitadio s. r. o., or any other institution carrying out the study or being involved in conducting/ organizing/ coordinating/ financing the trial

研究者

相似试验